Erratum: Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biologic diseasemodifying antirheumatic drugs.
Ontology highlight
SUBMITTER:
PROVIDER: S-EPMC5446002 | biostudies-literature | 2017 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA